ACannabis 2020 - Medicinal cannabis - scientist
3 - 4 March, 2020
Tickets on sale now

A Message from the Chair

"ACannabis is the platform to gain a deep understanding of ground-breaking research, an inside perspective on global trends and a unique opportunity for the agritech and medtech sector to have the conversations required to leverage our advantages."

Peter Crock
Medicinal Cannabis Industry Australia

Peter Crock
Peter Crock - CEO - Medicinal Cannabis Industry Australia

Why is ACannabis Different?

ACannabis is different to other events currently happening across Australia because it will:

  • Increase the capability of the Australian ecosystem
  • Build a productive bridge between research and industry
  • Accelerate the reputation of being a clean green medicinal supplier
  • Position Australia as an active player in the international medicinal cannabis ecosystem
  • Encourage investment into the wellbeing of patients
  • Create a platform for patient advocates to be heard
  • An opportunity to establish patient focused policies
  • Create one location to see what is happening across the medicinal cannabis industry


All tickets are for 1.​5 days and include: Access to all elements of the event (including exhibition hub and all sessions), morning / afternoon tea and lunch catering as well as food, beverages and entertainment at the networking event at the conclusion of Day 1 formalities.

Click here to read the terms and conditions associated with all ticket purchases.
*Please note that a processing fee is applicable when completing the registration through eventbrite.
Early Bird Registration
On sale until 5.​00pm AEDT 20 December 2020. $825 incl. GST*
Get Ticket
Standard Registration
On sale from 5.​00pm AEDT 20 December 2020. $1,100 incl. GST*
Become a Partner!

Interested in becoming a partner of ACannabis? Download our Partnership and Exhibition Prospectus or contact us for a tailored solution to meet your needs.


Founding Partners

See more
Join Us!

Register your interest to attend and stay up to date with our latest news.